While vascular endothelial growth factor inhibitors (i.e., anti-VEGF medications) have become the mainstay of treatment for exudative AMD, there are no approved therapies for non-exudative AMD [64] except for the combination of nutritional supplements demonstrated in the Age-Related Eye Disease Studies (AREDS [65] and AREDS2 [66]). The gene discussed is VEGFA; the disease is age-related macular degeneration.